Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0248-8663(89)80011-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Not Available].
Pan Afr Med J
April 2018
Equipe de Recherche en Santé et Nutrition du Couple Mère-Enfant, Faculté de Médecine et de Pharmacie de Rabat, Université Mohamed V, Service de Médecine et Réanimation Néonatales, Centre Hospitalier Ibn Sina, Rabat, Maroc.
Neonatal thrombopenia is the most common hemostatic abnormality in newborns. It is defined as a platelet count below 150.000/mm.
View Article and Find Full Text PDFAquaporin-4 positive neuromyelitis optica spectrum disorders secondary to thrombopenic purpura: A case report.
Medicine (Baltimore)
January 2017
aDepartment of Neurology, the First Hospital of Jilin University bDepartment of Ophthalmology, the Second Hospital of Jilin University, Changchun cCurrent address: Department of Life Sciences, the National Natural Science Foundation of China, Beijing, China.
Rationale: Neuromyelitis optica spectrum disorders (NMOSD) is considered as an immune-mediated disorder in the central nervous system (CNS). Numerous autoimmune diseases are frequently complicated with NMOSD and distinct clinical characteristics are noted in NMOSD patients with other autoimmune diseases. However, to our best knowledge, co-occurrence of NMOSD and thrombopenic purpura is rarely identified.
View Article and Find Full Text PDFControl of thrombotic thrombocytopenic purpura by sirolimus in a child with juvenile myelomonocytic leukemia and somatic N-RAS mutation.
Pediatr Blood Cancer
October 2014
Federal Research Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
We describe an infant who developed juvenile myelomonocytic leukemia (JMML) at the age of 6 months. Myeloproliferation was effectively controlled by low-dose cytosine arabinoside and 13-cis retinoic acid therapy. Two years after therapy for JMML was stopped, at the age of 5 years, the patient developed autoimmune thrombotic thrombocytopenic purpura (TTP).
View Article and Find Full Text PDF[Physiopathology of idiopathic thrombopenic purpura].
Rev Med Interne
October 2009
INSERM U517, IFR 100, Faculté de Médecine, 7 Boulevard Jeanne d'Arc, 21079 Dijon, France.
[Immune thrombocytopenic purpura: pathophysiology and treatment].
Transfus Clin Biol
May 2009
Service de Médecine Interne, Centre de Référence Labélisé de Prise en Charge des Cytopénies Auto-immunes de l'Adulte, 94010 Créteil cedex, France.
Immune thrombopenic purpura (ITP) is an autoimmune disease characterized by a peripheral destruction of platelets. B lymphocytes play a key role but pathophysiology is more complex, involving humoral and cellular immunity associated with an inappropriate platelet production. The treatment of ITP is still based on uncontrolled studies.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!